Early work identified antibodies directed against the metabotropic glutamate receptor, mGluR1, in rare patients with Hodgkin's disease and cerebellar ataxia (18) and of antibodies directed against mGluR5 in patients with limbic encephalitis associated with Hodgkin's disease (19). The gene discussed is GRM1; the disease is Hodgkins lymphoma.